Figures & data
Figure 1 Structural heterogeneity of dipeptidyl peptidase-4 (DPP-4) inhibitors.
Figure 2 Chemical structure of teneligliptin.
Figure 3 Continuous glucose monitoring results during treatment with gliclazide alone (day 1) and gliclazide plus teneligliptin (days 2 to 4).
Notes: The symbols at the bottoms of the figures indicate the times of meals. The round symbols on or close to the wavy lines indicate the times and values of calibration.
